C L Shapiro|D F Hayes - JoVE Visualize

Showing results (41-50 of 121) with videos related to

Pageof 13

Sort By:

Biochemistry|December 27, 1977

Methylation of glucagon, characterization of the sulfonium derivative, and regeneration of the native covalent structureT M Rothgeb, B N Jones, D F Hayes, et al.

Journal of Comparative Pathology|August 29, 2016

Epithelial Cell Adhesion Molecule Expression in Canine TumoursD H Thamm, D F Hayes, T Meuten, et al.

Blood|February 1, 1988

Genetically determined polymorphism of the circulating human breast cancer-associated DF3 antigenD F Hayes, H Sekine, D Marcus, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995

Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancerC L Vogel, J Schoenfelder, I Shemano, et al.

Cancer Research|July 15, 1988

Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancerC Tondini, D F Hayes, R Gelman, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1992

Immunocytochemical determination of the estrogen-regulated proteins Mr 24,000, Mr 52,000 and DF3 breast cancer associated antigen: clinical value in advanced breast cancer and correlation with estrogen receptorL Damstrup, J Andersen, D W Kufe, et al.

Molecular and Cellular Biology|May 1, 1981

The aromatic amino acid pathway branches at L-arogenate in Euglena gracilisG S Byng, R J Whitaker, C L Shapiro, et al.

Cancer Research|February 15, 1990

Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrowC Tondini, S A Pap, D F Hayes, et al.

The Journal of Clinical Investigation|May 1, 1985

Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patientsD F Hayes, H Sekine, T Ohno, et al.

Cancer Research|May 1, 1992

Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigenL Perey, D F Hayes, P Maimonis, et al.

Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:

Pageof 13

Biochemistry|December 27, 1977

Methylation of glucagon, characterization of the sulfonium derivative, and regeneration of the native covalent structureT M Rothgeb, B N Jones, D F Hayes, et al.

Journal of Comparative Pathology|August 29, 2016

Epithelial Cell Adhesion Molecule Expression in Canine TumoursD H Thamm, D F Hayes, T Meuten, et al.

Blood|February 1, 1988

Genetically determined polymorphism of the circulating human breast cancer-associated DF3 antigenD F Hayes, H Sekine, D Marcus, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995

Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancerC L Vogel, J Schoenfelder, I Shemano, et al.

Cancer Research|July 15, 1988

Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancerC Tondini, D F Hayes, R Gelman, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1992

Immunocytochemical determination of the estrogen-regulated proteins Mr 24,000, Mr 52,000 and DF3 breast cancer associated antigen: clinical value in advanced breast cancer and correlation with estrogen receptorL Damstrup, J Andersen, D W Kufe, et al.

Molecular and Cellular Biology|May 1, 1981

The aromatic amino acid pathway branches at L-arogenate in Euglena gracilisG S Byng, R J Whitaker, C L Shapiro, et al.

Cancer Research|February 15, 1990

Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrowC Tondini, S A Pap, D F Hayes, et al.

The Journal of Clinical Investigation|May 1, 1985

Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patientsD F Hayes, H Sekine, T Ohno, et al.

Cancer Research|May 1, 1992

Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigenL Perey, D F Hayes, P Maimonis, et al.

Pageof 13